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L 
ndmark studies by Mosmann and Coffman in the mid- 
to-late 1980s established  the division of a number of 
murine CD4 § T cells clones into distinct subsets, designat- 
ed Thl and Th2 cells, that mediate their effector functions 
through the elaboration of distinct groups of cytokines (1). 
Thl cells uniquely generate IFN-% lymphotoxin, and Ib2 
after stimulation, whereas Th2 cells uniquely generate I1-4, 
11-5, 11.-9, 11-10, and I1-13. Both subsets produce additional 
cytokines, such as 11-3 and GM-CSE Not surprisingly, based 
on the known effects of these cytokines, Thl cells are adept 
at macrophage activation and immunoglohulin selection for 
isotypes (IgG2a and IgG3) that mediate antibody-dependent 
cellular cytotoxicity and complement activation. Such cells 
have been demonstrated in numerous infectious disease models 
to activate appropriate host defense against  facuhative and 
obligate intracellular microbes, including viruses, bacteria, 
yeast, and protozoa. In some of these infectious disease sys- 
tems, Th2 cells have proven deleterious, largely through the 
ability of certain cytokines, particularly I1-4, I1-10, and IL-13, 
to downregulate macrophage activation, even in the pres- 
ence of IFN-y (2). 
Aside from those activities which might be important in 
moderating macrophage-mediated inflammatory capacity, 
cytokines released by Th2 cells favor the production and ac- 
tivation of mast cells and eosinophils, and stimulation of B 
cell growth, differentiation, and isotype switching to cells 
producing IgE and IgG1.  These host responses  have long 
been noted to characterize those seen during infection by in- 
testinal  helminths. Substantial  controversy has  arisen over 
whether such responses  are helpful or harmful. Are these 
infestations examples of chronic infections that evade effec- 
tive host defense, such that the body must downregulate the 
immune response to minimize tissue damage, or do these 
Th2 responses limit the extent of parasitization?  Examples 
supporting either hypothesis occur in both human and ro- 
dent studies (3), but the report by Finkelman et al. in this 
issue of The Journal of F_.xperimental Medicine (4) clearly demon- 
strates not only the protective role of Th2 responses in hel- 
minth infection, but also the deleterious effect of interventions 
(e.g.,  IL-12) that promote Thl responses. 
The question of Thl/Th2 bias in infectious disease has 
become of more than academic interest because of recent un- 
derstanding regarding the priming and differentiation of Thl 
and Th2 effector cells that permits the manipulation of this 
process. The best available data, derived both from limiting 
dilution analysis (5) and studies in T cell receptor transgenic 
mice (6,  7),  is that naive CD4 § T  cells have the capacity 
to differentiate  into either Thl or Th2 cells, and that this 
process is markedly influenced by the cytokine milieu dur- 
ing initial priming by specific antigen. Naive T cells gener- 
ate I1-2 when activated  by the appropriate MHC-peptide 
complex and  costimulatory signals,  and  progress rapidly 
through a multipotential cell that generates a mixed spec- 
trum of cytokines, including I1-2, IL-4, and IFN-3'. Although 
many immune responses probably retain this mixed pheno- 
type, designated the Th0 subset, infectious agents frequent- 
ly cause polarization of responses to either the Thl or Th2 
types, presumably because they alter the cytokine milieu dur- 
ing priming. Organisms that induce Thl responses, such as 
Listeria, Toxoplasma, and the tissue forms of Leishmania, con- 
tain antigens that trigger I1.-12 release from macrophages 
(8-10).  I1-12, in turn, directly primes CD4 § cells towards 
a Thl phenotype (8). Schistosome eggs constitute the pre- 
dominant antigens that polarize the immune response to- 
wards Th2 cells in the murine model of schistosomiasis. 
Recently, an egg-derived oligosaccharide  was demonstrated 
to induce IL-10 production from B cells (11). IL-10, in turn, 
has been demonstrated to promote Th2 development of na- 
ive CD4 + T  cells (6).  Further study of additional organ- 
isms will be required to confirm whether these examples will 
be extrapolated to all polarized responses, but the important 
point is that by knowing the signals, investigators have begun 
to manipulate responses in ways that reveal the underlying 
contributions by individual components of a muhifaceted im- 
mune response. 
Such studies have been put to the test in three murine models 
of helminth infection and, in each, the results are a resounding 
vote of confidence for the protective role of the Th2 response 
in intestinal infestation. Each system has sufficiently different 
nuances worth examining for the non-worm biologist. Trichuris 
muris, or murine whipworm, has an entirely enteric life cycle, 
maturing in the intestinal mucosa to the egg-laying adults 
that reside in the cecum and large bowel. Work from the 
Grencis laboratory has identified resistant (BALB/k) mice that 
expulse adult worms by 35 d and demonstrate immunity to 
rechallenge,  and susceptible (AKK) mice that maintain per- 
sistent infection (12). These disparate outcomes are correlated 
with Th2 or Thl cytokine production by mesenteric lymph 
node cells in the resistant or susceptible strains, respectively. 
Neutralization of IFN-3' allowed  susceptible strains  to ex- 
pulse worms, whereas blocking I1-4 using anti-IL-4K  anti- 
body resulted in persistent infection in resistant mice. Fur- 
ther,  administration of IL-4 (in the form of IL4/anti-IL-4 
complexes [13]) conferred a resistant phenotype (worm ex- 
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not only was IL-4 demonstrated to be beneficial, but IFN-y 
was demonstrated to be detrimental. 
Heligmosomoidespolygyrus also leads an enteric life, invading 
the mucosa to molt several times before emerging as egg- 
laying adults that reside in the upper small bowel where the 
worms reside for months. Infected mice are resistant to addi- 
tional infestations if rechallenged, however, which is an example 
of concomitant immunity. The latter can be quantitated ex- 
perimentally by drug-curing infected mice and demonstrating 
that rechallenge inocula are rapidly expulsed over 2-3 wk. 
Such concomitant immunity was completely blocked by ad- 
ministration of anti-IL-4 and anti-IL-4R antibodies, thus im- 
plicating IL-4 in mediating host defense (14). Immunity was 
also absent when IL-4 gene knockout mice were infected, drug- 
cured, and secondarily challenged with H. polygyrus (Le Gros, 
G., personal communication). Further, administration of IL-4 
complexes enhanced expulsion during primary infection. 
Nippostrongylus  brasiliensis is a rat parasite that has been 
adapted to the mouse through repeated passage.  Larvae are 
inoculated  subcutaneously,  migrate to  the vascular  space, 
through the lungs, and up the trachea before being swallowed 
to gain access to the intestinal lumen. There, organisms begin 
laying eggs, although production is short-lived, and adults 
are expulsed by approximately 10 d. Secondary challenges are 
rebuffed more quickly. Infection generates tremendous Th2 
responses, permitting interventions designed to test the com- 
ponents of normal immunity. Studies performed by Finkelman, 
Urban, Gause, and their colleagues have provided a number 
of insights. First, as in the T. muris system, IFN-3, or IFN-oe 
increased the duration of egg-laying and significantly delayed 
expulsion of the worms (15). When administered during an- 
tigen priming,  these cytokines have been demonstrated to 
bias T cells towards the Thl phenotype. Second, as demon- 
strated in this issue,  IL-12 had similar but more profound 
effects,  and these effects were correlated with the capacity 
of IL-12 to  enhance endogenous IFN-3, production while 
abrogating production of the Th2 cytokines IL-4, ILS, and 
IL-9 (4).  As predicted, such effects blocked intestinal mast 
cell hypertrophy, eosinophilia, and IgE production. Coad- 
ministration of anti-IFN-3, could abolish most of these effects, 
although eosinophilia remained curiously IFN-3, independent. 
Third, adm:'nistration of IL-12 during secondary rechallenge 
had little effect on worm persistence, egg-laying, or on the 
production of IL-4, IL-5, or IL-9 by mesenteric lymph node 
cells. Even in the primary infection, IL-12 had to be admin- 
istered within the first 4-6 d in order to achieve maximum 
effects, suggesting that committed Th2 cells, as suggested 
by additional studies elsewhere (16), may not express IL-12 
receptors like naive, Th0, or Thl cells. Lastly, these studies 
raise some caution in considerations of the therapeutic role 
of Ib12 in boosting cellular immunity, since immunity against 
these intestinal helminths was clearly compromised because 
of the inhibition of Th2 cell development. 
One of the more fascinating aspects  of these systems re- 
mains the mechanism(s) by which worms are actually ex- 
pulsed.  Although  depletion  of  CD4 +  cells  blocks  the 
normal expulsion of N. brasiliensis, antibodies to II~3, II.-4, 
IbS,  and II.-9 have no effect on the course of infection in 
normal mice, despite the demonstrable abrogation of mast 
cell hyperplasia,  eosinophilia, and IgE production (4, 17, 18). 
It is surprising that administration of IL-4 complexes to SCID 
mice that are normally unable to expulse N. brasiliensis caused 
expulsion of the worms over a 6-d period (Finkelman, F., 
personal communication). The efficacy of Ib4 and the ineffec- 
tiveness of anti-Ib4 antibodies in modulating the disease in 
normal mice raises the possibility that Ib13, a cytokine closely 
related to IL-4 in structure and function, may mediate these 
IL-4-independent effects (19, 20). Indeed, IL-13 has been shown 
to bind to components shared by the Ib4 receptor (21). Fur- 
ther, these studies point out that the traditional effectors of 
helminth biology-eosinophils, mast cells, and IgE-are not 
required for host defense in these systems. A  search for Ib 
4-inducible molecules involved in inflammation, such as 15- 
lipoxygenase expressed in human monocytes (22) or pancreatic 
lipase expressed in routine cytotoxic T  cells (23),  might be 
an instructive way to connect the immune system to intes- 
tinal physiology. Perhaps the final lesson from these studies 
is in pointing out that the ultimate judgment regarding the 
appropriate or inappropriate nature of an immune response 
can only be defined within the context in which it occurs. 
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